Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 10;11(12):e055455.
doi: 10.1136/bmjopen-2021-055455.

Study protocol for a randomised clinical trial of a decision aid and values clarification method for parents of a fetus or neonate diagnosed with a life-threatening congenital heart defect

Affiliations

Study protocol for a randomised clinical trial of a decision aid and values clarification method for parents of a fetus or neonate diagnosed with a life-threatening congenital heart defect

Rebecca K Delaney et al. BMJ Open. .

Abstract

Introduction: Parents who receive the diagnosis of a life-threatening, complex heart defect in their fetus or neonate face a difficult choice between pursuing termination (for fetal diagnoses), palliative care or complex surgical interventions. Shared decision making (SDM) is recommended in clinical contexts where there is clinical equipoise. SDM can be facilitated by decision aids. The International Patient Decision Aids Standards collaboration recommends the inclusion of values clarification methods (VCMs), yet little evidence exists concerning the incremental impact of VCMs on patient or surrogate decision making. This protocol describes a randomised clinical trial to evaluate the effect of a decision aid (with and without a VCM) on parental mental health and decision making within a clinical encounter.

Methods and analysis: Parents who have a fetus or neonate diagnosed with one of six complex congenital heart defects at a single tertiary centre will be recruited. Data collection for the prospective observational control group was conducted September 2018 to December 2020 (N=35) and data collection for two intervention groups is ongoing (began October 2020). At least 100 participants will be randomised 1:1 to two intervention groups (decision aid only vs decision aid with VCM). For the intervention groups, data will be collected at four time points: (1) at diagnosis, (2) postreceipt of decision aid, (3) postdecision and (4) 3 months postdecision. Data collection for the control group was the same, except they did not receive a survey at time 2. Linear mixed effects models will assess differences between study arms in distress (primary outcome), grief and decision quality (secondary outcomes) at 3-month post-treatment decision.

Ethics and dissemination: This study was approved by the University of Utah Institutional Review Board. Study findings have and will continue to be presented at national conferences and within scientific research journals.

Trial registration number: NCT04437069 (Pre-results).

Keywords: congenital heart disease; paediatric cardiology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study flow. REDCap, Research Electronic Data Capture.

Similar articles

Cited by

References

    1. Oster ME, Lee KA, Honein MA, et al. . Temporal trends in survival among infants with critical congenital heart defects. Pediatrics 2013;131:e1502–8. 10.1542/peds.2012-3435 - DOI - PMC - PubMed
    1. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890–900. 10.1016/S0735-1097(02)01886-7 - DOI - PubMed
    1. Reller MD, Strickland MJ, Riehle-Colarusso T, et al. . Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008;153:807–13. 10.1016/j.jpeds.2008.05.059 - DOI - PMC - PubMed
    1. Peterson C, Dawson A, Grosse SD, et al. . Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol Teratol 2013;97:664–72. 10.1002/bdra.23165 - DOI - PMC - PubMed
    1. Barron DJ, Kilby MD, Davies B, et al. . Hypoplastic left heart syndrome. Lancet 2009;374:551–64. 10.1016/S0140-6736(09)60563-8 - DOI - PubMed

Publication types

Associated data